These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 10499474

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ, Kim JI, Lee JS, Jun EJ, Oh JH, Cheung DY, Chung WC, Kim BW, Kim SS.
    World J Gastroenterol; 2015 Jan 07; 21(1):351-9. PubMed ID: 25574111
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
    Adamek RJ, Pfaffenbach B, Szymanski C.
    Helicobacter; 1998 Sep 07; 3(3):206-11. PubMed ID: 9731993
    [Abstract] [Full Text] [Related]

  • 32. Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer.
    Vcev A, Stimac D, Ivandić A, Vceva A, Takac B, Pezerović D.
    Aliment Pharmacol Ther; 2000 Jan 07; 14(1):69-72. PubMed ID: 10632647
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy.
    Eisig JN, André SB, Silva FM, Hashimoto C, Moraes-Filho JP, Laudanna AA.
    Arq Gastroenterol; 2003 Jan 07; 40(1):55-60. PubMed ID: 14534667
    [Abstract] [Full Text] [Related]

  • 35. High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin.
    Furuta T, Shirai N, Xiao F, Takashita M, Sugimoto M, Kajimura M, Ohashi K, Ishizaki T.
    Hepatogastroenterology; 2003 Jan 07; 50(54):2274-8. PubMed ID: 14696516
    [Abstract] [Full Text] [Related]

  • 36. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA, Pajares JM, Santander C, Carpintero P, Hermida C, Lara S, García Grávalos R.
    J Gastroenterol; 1996 Nov 07; 31 Suppl 9():48-52. PubMed ID: 8959519
    [Abstract] [Full Text] [Related]

  • 37. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
    Kalach N, Benhamou PH, Bergeret M, Gottrand F, Husson MO, Barbier C, Dupont C, Raymond J.
    Arch Pediatr; 2002 Feb 07; 9(2):130-5. PubMed ID: 11915493
    [Abstract] [Full Text] [Related]

  • 38. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
    Svoboda P, Kantorová I, Ochmann J, Doubek J, Kozumplík L, Marsová J.
    Hepatogastroenterology; 1997 Feb 07; 44(15):886-90. PubMed ID: 9222709
    [Abstract] [Full Text] [Related]

  • 39. One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
    Labenz J, Stolte M, Peitz U, Tillenburg B, Becker T, Börsch G.
    Aliment Pharmacol Ther; 1996 Apr 07; 10(2):207-10. PubMed ID: 8730252
    [Abstract] [Full Text] [Related]

  • 40. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.
    Clin Ther; 2008 Mar 07; 30(3):528-34. PubMed ID: 18405790
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.